Related Experiment Video
Updated: May 12, 2026
10:21
Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells
Published on: February 21, 2018
Dysregulated RasGRP1 responds to cytokine receptor input in T cell leukemogenesis
Catherine Hartzell1, Olga Ksionda, Ed Lemmens
1Department of Anatomy, University of California, San Francisco, San Francisco, CA 94143, USA.
Science Signaling
|March 28, 2013
Summary
Ras guanine nucleotide exchange factor RasGRP1 promotes T cell acute lymphoblastic leukemia (T-ALL) by activating Ras signaling. Increased RasGRP1 expression is linked to T-ALL proliferation, suggesting its potential as a stratification marker.
Area of Science:
- Oncology
- Molecular Biology
- Immunology
Background:
- Enhanced signaling by the small guanosine triphosphatase Ras is a hallmark of T cell acute lymphoblastic leukemia/lymphoma (T-ALL).
- The precise mechanisms driving Ras activation in T-ALL remain incompletely understood.
- RasGRP1 is identified as a key guanine nucleotide exchange factor involved in Ras activation.
Purpose of the Study:
- To investigate the role of RasGRP1 in T-ALL pathogenesis.
- To elucidate the mechanisms by which RasGRP1 contributes to leukemogenesis.
- To evaluate RasGRP1 as a potential biomarker for T-ALL stratification.
Main Methods:
- Analysis of RasGRP1 expression in pediatric T-ALL patient samples.
- Leukemia screens in wild-type and K-Ras(G12D) mutant mice.
- Investigation of cytokine receptor-activated Ras pathways.
- Assessment of RasGRP1's impact on T-ALL cell proliferation in vivo.
- Evaluation of Ras signaling dynamics and effector kinase activation.
Main Results:
- Increased RasGRP1 expression was observed in a significant proportion of pediatric T-ALL patients.
- RasGRP1 promotes T-ALL through a distinct cytokine receptor-activated Ras pathway, independent of oncogenic K-Ras(G12D) mutations.
- RasGRP1 activation stimulates T-ALL cell proliferation in vivo via Ras signaling.
- Reduction of RasGRP1 abundance curtails cytokine-stimulated Ras signaling and T-ALL proliferation.
- Dynamic activation patterns of downstream effector kinases were observed in individual T-ALLs.
Conclusions:
- RasGRP1 is a critical Ras activator contributing to T-ALL development and progression.
- RasGRP1 represents a novel therapeutic target and a potential stratification marker for T-ALL based on its abundance and distinct signaling pathway.
- Understanding RasGRP1's role offers insights into T-ALL heterogeneity and treatment strategies.
Related Concept Videos
02:38The Ras Gene
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Ras is a superfamily...
01:24Small GTPases - Ras and Rho
Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Three regulatory proteins control their activity:
02:23Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
01:07MAPK Signaling Cascades
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
02:38Mitogens and the Cell Cycle
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...